SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-015617
Filing Date
2017-03-20
Accepted
2017-03-20 16:01:24
Documents
5
Period of Report
2017-03-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v462102_8k.htm 8-K 22508
2 EXHIBIT 3.01 v462102_ex3-01.htm EX-3.01 110112
3 EXHIBIT 4.01 v462102_ex4-01.htm EX-4.01 8613
4 EXHIBIT 10.01 v462102_ex10-01.htm EX-10.01 216194
5 EXHIBIT 10.02 v462102_ex10-02.htm EX-10.02 107175
  Complete submission text file 0001144204-17-015617.txt   465981
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55331 | Film No.: 17701400
SIC: 2834 Pharmaceutical Preparations